Unraveling Hurthle cell lesions of the thyroid using molecular findings.
Wong KS.
Cancer Cytopathol. 2022 Jun;130(6):405-406. doi: 10.1002/cncy.22567. Epub 2022 Mar 14.
PMID:35285577
Hurthle cell lesions of the thyroid: Progress made and challenges remaining.
Wong KS, Angell TE, Barletta JA, Krane JF.
Cancer Cytopathol. 2021 May;129(5):347-362. doi: 10.1002/cncy.22375. Epub 2020 Oct 27.
PMID:33108684
Hurthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.
Coca-Pelaz A, Rodrigo JP, Shah JP, Sanabria A, Al Ghuzlan A, Silver CE, Shaha AR, Angelos P, Hartl DM, Mäkitie AA, Olsen KD, Owen RP, Randolph GW, Simó R, Tufano RP, Kowalski LP, Zafereo ME, Rinaldo A, Ferlito A.
Adv Ther. 2021 Oct;38(10):5144-5164. doi: 10.1007/s12325-021-01876-7. Epub 2021 Aug 22.
PMID:34423400
Genetics, Diagnosis, and Management of Hurthle Cell Thyroid Neoplasms.
McFadden DG, Sadow PM.
Front Endocrinol (Lausanne). 2021 Jun 10;12:696386. doi: 10.3389/fendo.2021.696386. eCollection 2021.
PMID:34177816
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.